Pulmera announced today that it received FDA 510(k) clearance for its CBeam 3D intraoperative imaging platform.
Pulmera, an emerging medical technology company developing next-generation intraoperative imaging solutions, today announced that it has received U.S. Food and Drug Administration 510(k) clearance for ...
Special Report: Optiscan Imaging has reached the halfway mark in its first in-human breast cancer imaging study at The Royal ...
Qaelon Medical and Scialytics today announced a strategic, non-exclusive partnership to integrate Qaelon's real-time physiologic GI data into Scialytics' AI-driven surgical analytics platform. The ...
An intramuscular Masson tumor in the deltoid muscle mimics a malignant vascular tumor on imaging, making surgical excision ...
Precision Spine launched its Reform Ti FS modular fenestrated screw system, according to a June 3 news release. The screw system is designed delivers PMMA bone cement through the screw shaft directly ...
Safety and efficacy of PD-1/PD-L1 inhibitor plus chemotherapy versus chemotherapy alone in esophageal squamous cell carcinoma: A systematic review and meta-analysis. Early versus delayed oral feeding ...
Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ...
Xenix Medical today announced FDA 510(k) clearance for the Riva Posterior Fixation System and the successful completion of ...
Optiscan Imaging and Mayo Clinic have extended their know-how agreement by three months after completing key development ...
On 29 May (Brazil local time), an orthopaedic surgical robot from Shenzhen, China, completed its first clinical launch in an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results